Cargando…
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
The development of several treatment options over the last 2 decades has led to a notable improvement in the survival of patients with multiple myeloma. Despite these advances, the disease remains incurable for most patients. Moreover, standard combinations of alkylating agents, immunomodulatory dru...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170343/ https://www.ncbi.nlm.nih.gov/pubmed/34104374 http://dx.doi.org/10.1177/20406207211019622 |